18F-FDG与68Ga-FAPI-04 PET/CT在评估透明细胞子宫内膜癌中的应用
18F-FDG and 68Ga-FAPI-04 PET/CT in Evaluating Clear-Cell Endometrial Cancer.
PubMed 文献 · Clin Nucl Med · 2023-01-01
一例60岁女性透明细胞子宫内膜癌患者接受新辅助化疗后仍无法手术,转诊评估病变范围,接受18F-FDG PET/CT与68Ga-FAPI-04 PET/CT检查;68Ga-FAPI-04 PET/CT在转移灶中显示出比18F-FDG PET/CT更高的摄取,表现更优。
要点
- 60岁女性透明细胞子宫内膜癌患者新辅助化疗后仍无法手术,转诊评估病变范围。
- 患者接受18F-FDG PET/CT与68Ga-FAPI-04 PET/CT两种显像。
- 68Ga-FAPI-04 PET/CT在转移灶中摄取高于18F-FDG PET/CT,表现更优。
核心结论
- 68Ga-FAPI-04 PET/CT在转移灶中显示出比18F-FDG PET/CT更高的摄取,表现优于18F-FDG PET/CT。
研究设计与样本
- 一例60岁女性透明细胞子宫内膜癌患者,新辅助化疗后无法手术,转诊评估病变范围,接受18F-FDG PET/CT与68Ga-FAPI-04 PET/CT检查。
主要发现
- 68Ga-FAPI-04 PET/CT在转移灶中显示出比18F-FDG PET/CT更高的摄取,表现更优。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 60-year-old woman diagnosed with clear cell endometrial carcinoma received neoadjuvant chemotherapy. However, the patient was inoperable and referred to our clinic to evaluate the extent of the disease. The patient underwent 18FDG PET/CT and 68Ga-FAPI (fibroblast activated protein inhibitor)-04 PET/CT scans. 68Ga-FAPI-04 PET/CT outperformed 18FDG PET/CT demonstrating higher uptake in the metastatic lesions.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Kiran MY, Has Simsek D, Sanli Y, et al. 18F-FDG and 68Ga-FAPI-04 PET/CT in Evaluating Clear-Cell Endometrial Cancer. Clin Nucl Med. 2023. PMID: 36607380. doi:10.1097/RLU.0000000000004532
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。